ISCTR – TCT 2018 Consensus Summit

As we build toward the culminating work of our past two summits, the ISCTR Board of Directors invites you to join us at the 2018 ISCTR – TCT Consensus Summit on Translational Pathways for Cardiovascular Devices, being held Friday, September 21, 2018, in San Diego, California. Speakers throughout the full-day symposium will focus on translational pathways for cardiovascular device development and iteration, with the goal of achieving final consensus on the direction those pathways follow.

This year, two pioneers in the development of transcatheter aortic valve replacement (TAVR) have been chosen as the recipients of the Glen and Marilyn Nelson Award for Innovation and Translation in Cardiovascular Medicine and will present the Keynote Address: Alain Cribier, MD, FACC, will talk about TAVR Development from Concept to First in Man followed by Martin B. Leon, MD, addressing TAVR Development from First in Man to Phase III and Beyond.

Alain Cribier, MD, FACC

Professor Cribier is the Medical Director of the Rouen Medical Training Center, a multidisciplinary center he created that is dedicated to learning medicine through simulation, video-conferences and training between surgeons, physicians, and experts, as well as Professor Emeritus at the Rouen University. Dr. Cribier had previously served as Professor of Medicine and Director of the Catheterization Laboratory at the University of Rouen. It was there he performed the world’s first balloon aortic valvuloplasty in 1986, and the world’s first mitral commissurotomy in 1995. When it was determined that the results of balloon aortic valvuloplasty were not sufficiently enduring in most patients, Dr. Cribier developed a transcatheter aortic valve implantation procedure and performed the world’s first such procedure in 2002. Born in Paris, Professor Cribier studied medicine at the University of Paris and completed his early residency training there. Upon receiving his certification in cardiology, as well as a diploma in law and health economics, Dr. Cribier was a cardiology resident at the University of Rouen; he also spent a year in an interventional cardiology fellowship at the Cedars-Sinai Hospital in Los Angeles, California.

The author of more than 1,500 journal articles, Dr. Cribier has received numerous degrees, awards, and recognitions for his lifelong dedication and contributions to interventional cardiology. These include the European Society of Cardiology Gold Medal and Andreas Grüntzig Award, the EuroPCR Ethica Award, TCT Achievement Award, and the Legend of Medicine award, and has been knighted with the Legion of Honor and Academic Palms.

Martin B. Leon, MD

The Director and Founder of TCT, Martin B. Leon, MD, is Professor of Medicine at Columbia University Medical Center, Director of the Center for Interventional Vascular Therapy, Director of the Cardiac Catheterization Laboratories, and on the Executive Board of the Columbia NewYork-Presbyterian Heart Valve Center. Dr. Leon is also the Founder and Chairman Emeritus of the Cardiovascular Research Foundation. Dr. Leon has served as principal investigator for more than 50 clinical trials that have helped shape the field of interventional cardiovascular medicine, including the PARTNER trials on transcatheter valve therapy for patients with aortic stenosis. Recognized with 10 international career achievement awards, Dr. Leon has co-authored more than 1,550 publications, performed more than 10,000 interventional procedures, led more than 100 international educational programs in interventional cardiology, and had a major impact as a thought leader and innovator in interventional cardiovascular device and drug therapies.  

Dr. Leon completed a fellowship in Cardiology at the Yale-New Haven Hospital. He completed medical school at the Yale School of Medicine, and his internship and residency in internal medicine at the Yale-New Haven Hospital. He was previously the Director of Cardiovascular Research and Education at the Lenox Hill Heart and Vascular Institute in New York and the Director of Clinical Research at the Washington Cardiology Center at the Washington Hospital Center and Clinical Professor of Medicine at Georgetown University Medical Center in Washington, DC. Earlier in his career, he served as a Clinical Associate, Senior Investigator, and Director of the Catheterization Laboratories in the Cardiology Branch of the National Heart, Lung and Blood Institute at the National Institutes of Health.

 

Cardiovascular Translational Research eTextbook

isctr-home-page-etextbook-ipad

Available now for iPad and web browsers.

Mission and Goals of ISCTR

 

ESC Congress 2018

Join ISCTR at ESC.18 in Munich for a new symposium on Cardiovascular Translational Research. Check back here for details. 

Become an ISCTR Member

In Translation

An ISCTR member publication

Clinical Trials

Find announcements and information about upcoming and existing clinical trials, as well as links to other sources on the internet…

Symposium

10th Annual Symposium summary information and presentation videos …

In the News

Check here for our latest press releases and media contact information …

ISCTR

International Society for
Cardiovascular Translational Research

The International Society for Cardiovascular Translational Research (ISCTR) is a non-profit organization that was founded in 2007 by Dr Nabil Dib with a goal to expedite scientific discovery to clinical application (patients).

Read more…

The Glen and Marilyn Nelson Award for Innovation and Translation in Cardiovascular Medicine

nelsons-1

Click to view ->

Journal of Cardiovascular Translational Research

jctr-journal

Click for details on Springer…